These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation. Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536 [TBL] [Abstract][Full Text] [Related]
9. Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis. Caparrós-Martín JA; Saladie M; Agudelo-Romero SP; Reen FJ; Ware RS; Sly PD; Stick SM; O'Gara F; Microbiome; 2023 Jun; 11(1):132. PubMed ID: 37312128 [TBL] [Abstract][Full Text] [Related]
10. Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis. Pittman JE; Wylie KM; Akers K; Storch GA; Hatch J; Quante J; Frayman KB; Clarke N; Davis M; Stick SM; Hall GL; Montgomery G; Ranganathan S; Davis SD; Ferkol TW; Ann Am Thorac Soc; 2017 Oct; 14(10):1548-1555. PubMed ID: 28708417 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis. Montgomery ST; Dittrich AS; Garratt LW; Turkovic L; Frey DL; Stick SM; Mall MA; Kicic A; J Cyst Fibros; 2018 Nov; 17(6):715-722. PubMed ID: 29884450 [TBL] [Abstract][Full Text] [Related]
12. Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease Persistence. Batson BD; Zorn BT; Radicioni G; Livengood SS; Kumagai T; Dang H; Ceppe A; Clapp PW; Tunney M; Elborn JS; McElvaney NG; Muhlebach MS; Boucher RC; Tiemeyer M; Wolfgang MC; Kesimer M Am J Respir Cell Mol Biol; 2022 Aug; 67(2):253-265. PubMed ID: 35486871 [TBL] [Abstract][Full Text] [Related]
14. Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis. O'Connor JB; Mottlowitz M; Kruk ME; Mickelson A; Wagner BD; Harris JK; Wendt CH; Laguna TA Front Cell Infect Microbiol; 2022; 12():805170. PubMed ID: 35360097 [TBL] [Abstract][Full Text] [Related]
16. Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction. Garić D; De Sanctis JB; Dumut DC; Shah J; Peña MJ; Youssef M; Petrof BJ; Kopriva F; Hanrahan JW; Hajduch M; Radzioch D Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158538. PubMed ID: 31678518 [TBL] [Abstract][Full Text] [Related]
17. Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis. Taylor SL; Leong LEX; Ivey KL; Wesselingh S; Grimwood K; Wainwright CE; Rogers GB; J Cyst Fibros; 2020 Nov; 19(6):923-930. PubMed ID: 32199729 [TBL] [Abstract][Full Text] [Related]
18. Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis. Jorth P; Ehsan Z; Rezayat A; Caldwell E; Pope C; Brewington JJ; Goss CH; Benscoter D; Clancy JP; Singh PK Cell Rep; 2019 Apr; 27(4):1190-1204.e3. PubMed ID: 31018133 [TBL] [Abstract][Full Text] [Related]
19. Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway. Balázs A; Mall MA Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S5-S12. PubMed ID: 31715090 [TBL] [Abstract][Full Text] [Related]